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Summary 
 
Background: Resident tissue macrophages are present in nearly every tissue of 
the body, where they fulfill global as well as tissue adapted functions. In bone 
tissue, they are called osteomacs. These cells play an important role in the 
support of bone formation and immune surveillance. Cathepsin S is a lysosomal 
protease that is involved in several cellular processes such as extracellular matrix 
(ECM) remodeling and antigen processing and presentation. Furthermore, 
cathepsin S influences the differentiation of mesenchymal stem cells (MSCs), the 
progenitors of the bone forming osteoblasts, as it favors their development 
towards the adipocyte lineage. 
Aim: In the present study, we investigated the possible influence of cathepsin S 
deficiency on osteomacs. We hypothesized a reduced number of F4/80+ 
macrophages, a decline in MHC (major histocompatibility complex) class II 
expression on these cells and a discreet bone phenotype. 
Methods: The presence and distribution of osteomacs in the spine of cathepsin S 
knockout and wild-type mice were determined by immunofluorescence stainings, 
using a monoclonal antibody against the surface molecule F4/80. The number of 
F4/80+ macrophages and their MHC class II expression were examined by flow 
cytometry analyses. Histomorphometric and micro-computed tomography 
measurements of the 5th lumbar vertebra were performed to evaluate alterations in 
the bone microarchitecture. 
Main results: In both mouse genotypes the number of F4/80+ cells was similar. 
Numerically cathepsin S knockout mice displayed an increased mean 
fluorescence intensity of the MHC II signal. Additionally, we found less mineralized 
bone tissue, thinner trabeculae and smaller osteocyte lacunae in the knockout 
mice. 
Conclusion: Cathepsin S deficient mice show a reproducible bone phenotype and 
evidence of macrophage activation. Currently pharmacologic inhibitors of 
cathepsin S are proposed for the treatment of obesity and several immune 
disorders; based on our findings we strongly advice to monitor bone turnover and 
bone mineral density in patients treated with cathepsin S inhibitors. 
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Zusammenfassung 
 
Hintergrund: Residente Gewebsmakrophagen sind in fast jedem Gewebe des 
Körpers vorhanden, wo sie sowohl gobale als auch an das Gewebe angepasste 
Funktionen erfüllen. Diese Zellen werden im Knochen „Osteomakrophagen“ 
genannt und spielen bei der Unterstützung der Knochenneubildung und 
Immunüberwachung eine wichtige Rolle. Cathepsin S ist eine lysosomale 
Protease, welche bei verschiedenen zellulären Prozessen, wie zum Beispiel dem 
Remodelling der extrazellulären Matrix oder der Antigenprozessierung und –
präsentation, eine wichtige Rolle spielt. Darüber hinaus beeinflusst Cathepsin S 
die Differenzierung von mesenchymalen Stammzellen (von denen auch die 
Osteoblasten abstammen) da es deren Entwicklung in Richtung der Adipozyten 
begünstigt. 
Ziel: Ziel dieser Studie war es zu untersuchen, ob die Cathepsin S Defizienz die 
Osteomakrophagen beeinflusst. Die der Arbeit zugrunde liegenden Hypothesen 
waren eine reduzierte Anzahl von F4/80+ Makrophagen, eine Abnahme der 
Hauptkompatibilitätskomplex (MHC) Klasse II Expression und ein dezenter 
Knochen-Phänotyp. 
Methoden: Die Anwesenheit und Verteilung von Osteomakrophagen in der 
Wirbelsäule von Cathepsin S Knockout- und Wildtyp-Mäusen wurde durch 
Immunfluoreszenz-Färbungen mit einem monoklonalen Antikörper gegen das 
Oberflächenmolekül F4/80 festgestellt. Die Anzahl der F4/80+ Makrophagen und 
deren MHC Klasse II Expression wurde mittels der Durchflusszytometrie 
untersucht. Zur Feststellung von Veränderungen der Knochenmikroarchitektur 
wurden histomorphometrische und mikro-Computertomographie Messungen des 
fünften Lendenwirbelkörpers durchgeführt. 
Resultate: In beiden Maus Genotypen waren Anzahl und Verteilung der F4/80+ 
Zellen gleich. Numerisch wiesen Cathepsin S Knockout Mäuse eine erhöhte Mean 
Fluorescence Intensity des MHC Klasse II Signals auf. Zusätzlich wurden ein 
vermindert mineralisiertes Knochengewebe, dünnere Trabekel und kleinere 
Osteozyten-Lakunen bei den Knockout Mäusen gefunden. 
 
- 4 - 
Schlussfolgerung: Cathepsin S defiziente Mäuse zeigen einen reproduzierbaren 
Knochen-Phänotyp und Hinweise auf Makrophagen-Aktivierung. Derzeit werden 
pharmakologische Cathepsin S Inhibitoren zur Behandlung der Adipositas und 
verschiedener immunologischer Erkankungen diskutiert; basierend auf unseren 
Ergebnissen raten wir dringend zu einer Überwachung des Knochenstoffwechsels 
und der Knochendichte bei Patienten, welche mit Cathepsin S Inhibitoren 
behandelt werden. 
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Introduction 
 
Bone 
In general, bone fulfills fundamental physical functions like supporting the 
constitution of the body, protecting the organs of an organism and enabling 
locomotion. In addition, bone is also very important for several processes on a 
more cellular and metabolic level. For instance, it serves as a mineral reservoir 
and provides a niche for haematopoietic stem cells (HSCs) [1]. Thus it is crucial for 
the formation of the cellular components of the blood including cells of the immune 
system [2].  
Bone is a strong, stable and highly organized tissue, but to be able to accomplish 
all its functions, it also has to be very dynamic and flexible. Therefore, it undergoes 
constant rebuilding to adjust itself to environmental changes and mechanical 
impacts. The basic concept of this two-edged characteristic can be found in the 
composition of this tissue. The mechanical strength and stability is achieved by the 
bone mineral that is mainly composed of hydroxyapatite crystals 
[Ca10(PO4)6(OH)2]. In contrast, the organic matrix, consisting primarily of type I 
collagen and additional other non collagenous proteins, is responsible for the 
elastic and flexible nature of bone [1]. 
Moreover, bone can be divided into two major types of bone tissue, the compact or 
cortical bone and the cancellous or trabecular bone. The cortical bone tissue 
builds up the outward layer of the bone and is very dense and stiff. On the 
contrary, the cancellous bone can be found on the inside where it is arranged in a 
complex, honeycomb-like network that harbors the bone marrow [1].  
 
Figure 1: Cortical (left) and trabecular (right) bone of a murine vertebral body. 3D models were 
assembled out of 231 scanned slices of a micro-computed tomography (µ-CT) measurement. 
- 6 - 
The inner and outer surface of the bone is coated by a thin layer that contains the 
main bone cell types. On the inside it is called endosteum, a one to two cells thick 
membrane that is in direct contact with the bone marrow. The periosteum on the 
outside is thicker and exhibits next to the inner cellular layer an additional dense 
fibrous layer [1, 3]. 
 
 
Figure 2: Hematoxylin and eosin (HE) staining of a murine vertebral body (original magnification: 10x). 
Spine of a female, three months old HIM:OF-1 mouse was fixed in 4 % paraformaldehyde (PFA), decalcified 
and embedded in paraffin. HE staining was performed on 4 µm thick sections. Nuclei are shown in purple, 
cytoplasm and bone matrix occur in red.  
 
Osteoblasts 
Osteoblasts are responsible for the formation of bone. They derive from 
mesenchymal stem cells (MSCs) that differentiate into osteoprogenitor cells. 
These cells are the source for osteoblasts, osteocytes as well as bone lining cells 
[4, 5]. Upon activation, they start to synthesize and secrete new, unmineralized 
bone matrix components (osteoid). Subsequently, they catalyze and regulate its 
mineralization. These metabolic processes are accompanied by a morphological 
change, as shown in Figure 3. Active osteoblasts become round, cuboidal and 
polarized [for review see 1].  
- 7 - 
Moreover, cells derived from osteoprogenitor cells are able to interact with the 
bone degrading osteoclasts. By producing osteoclastogenic factors such as 
macrophage colony-stimulating factor (M-CSF), receptor activator of nuclear 
factor-κ B ligand (RANKL) and osteoprotegerin (OPG), they contribute to the 
recruitment and differentiation process of osteoclasts [6, 7].  
The soluble M-CSF is crucial for the maturation and survival of cells of the 
monocyte-macrophage cell line [8]. This is achieved by the activation of the colony 
stimulating factor-1 (CSF-1) receptor that is also present on osteoclasts. RANKL 
initiates osteoclastogenesis by binding to the receptor activator of NF-κB (RANK) 
on the osteoclast surface. This interaction can by prevented by the osteoblastic 
expression of OPG, a soluble competitor of RANKL. Thus, osteoblasts can control 
osteoclast differentiation and activity by the regulation of the amount of RANKL 
and its decoy receptor OPG [for review see 9, 10]. 
 
 
Figure 3: HE stained section of a murine vertebra showing active, cuboidal osteoblasts (original 
magnification: 40x). Vertebral column was fixed in 4 % PFA, decalcified for 5 days in Tris/EDTA and finally 
embedded in paraffin. Four µm thick sections were stained with hemalum and eosin Y. 
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Osteocytes 
Active osteoblasts synthesize and secrete osteoid and regulate its subsequent 
mineralization. During bone formation, a part of them gets gradually surrounded 
and finally trapped within the mineralized bone matrix. They change their 
morphology from cuboidal to more stellate-shaped and differentiate into fully 
mature osteocytes [11, 12].  
With their long processes inside interconnecting channels, the so called canaliculi, 
they build up a huge network throughout the whole bone. Via gap junctions they 
keep contact with other engulfed osteocytes, each lying in its distinct lacunae, as 
well as with osteoblasts and bone lining cells at the bone surface. This complex 
lacunocanicular system enables an exchange of nutrients and information [12, 13]. 
As a result, they can forward information they get through mechanosensation [14] 
to other bone cells and thereby contribute to the coordination of bone structure 
and turnover.  
 
 
Figure 4: Osteocytes lying in individual lacunae in a HE stained section of a murine vertebral column 
(original magnification: 40x). Spines were prepared as described in Figures 2 and 3. Cytoplasm and bone 
matrix are shown in red, nuclei occur purple. 
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Bone lining cells 
The bone lining cells mainly build up the cellular part of the endosteum and 
periosteum and cover the bone if it is in a quiescent state. Like osteoblasts and 
osteocytes, they derive from osteoprogenitor cells with mesenchymal origin [1].  
If bone remodeling occurs, they retreat or redifferentiate into active, osteoid-
producing osteoblasts. Moreover, they may participate in the preparation of the 
bone surface prior the onset of bone resorption [15] and bone formation [16] 
during bone remodeling. Thus, they can participate in bone dynamics and 
subsequently contribute to bone integrity.  
In addition, these thin and elongated cells form a kind of protective barrier on the 
bone surface. As a result, they may be involved in mineral homeostasis by 
regulating the exchange of mineral ions between the bone and its environment 
[17]. 
 
 
Figure 5: Bone lining cells in a HE stained section of a murine vertebral column (original 
magnification: 40x). Spines were prepared as described in Figures 2 and 3. Cytoplasm and bone matrix 
occur red, nuclei are stained purple. 
 
- 10 - 
Osteoclasts 
Osteoclasts are of haematopoietic origin and develop along the myeloid lineage 
[18, 19]. They degrade bone tissue by breaking down the mineralized matrix and 
resorbing its liberated components. The recruitment and activation of osteoclast 
precursors is regulated via factors like M-CSF, RANKL and OPG. These 
molecules can be synthesized by osteoblasts and osteoblastic stromal cells, in 
response to a variety of factors such as parathyroid hormone (PTH), parathyroid 
hormone-related peptide (PTHrP), tumor necrosis factor-α (TNF-α) and interleukin-
1 (IL-1) [6].  
Upon activation, the osteoclast precursors of the monocyte-macrophage lineage 
fuse to form large, multinucleated cells. These polykaryons become polarized and 
form a specialized compartment at the bone facing site that is isolated by an actin 
sealing ring. Here, they start to secrete proteolytic enzymes and hydrogen chloride 
(HCl). As a result of the acidification within this resorption cavity, bone mineral 
gets dissolved. On the other hand, the organic matrix gets degraded by the 
secreted collagenolytic enzymes such as cathepsin K and matrix 
metalloproteinases. Released matrix components are subsequently removed via 
transcytosis to the non bone facing site of the osteoclast [for review see 18]. 
 
Figure 6: A multinucleated TRAP-stained osteoclast in a bone marrow culture (original 
magnification: 10x). Bone marrow cells were incubated for one week in standard medium containing 10-8 
M 1,25(OH)2D3 (37 °C,  % COs and 95 % air humidity). Medium was changed every 3 days. Cells were 
stained for TRAP using the Leukocyte Acid Phosphatase Kit (Sigma 387A-1KT). TRAP = tartrate-resistant 
acid phosphatise 
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Bone remodeling 
Bone remodeling is a highly coordinated metabolic process that involves the action 
of bone forming osteoblasts and bone degrading osteoclasts. The maintenance of 
the overall bone mass is ensured by the strict coupling of the activity of these two 
bone cells. This dynamic process takes place at the inner and outer bone surface 
in response to mechanical impacts, microdamages or metabolic stimuli [1, 6].  
A remodeling cycle starts with the recruitment of preosteoclasts that develop from 
the monocyte-macrophage lineage. The expression of M-CSF, RANKL and OPG 
by osteoblasts and bone marrow stromal cells subsequently drives the fusion and 
differentiation to mature, multinucleated osteoclasts. Attachment of osteoclasts is 
enabled by the removal of unmineralized osteoid from the bone surface by bone 
lining cells [15]. During bone degradation, osteoclasts get polarized and display 
several distinct membrane domains. At the bone facing site is the ruffled border, 
encircled by the sealing zone (actin ring) that enables the establishment of an 
isolated compartment. Here, collagenolytic enzymes and hydrogen chloride (HCl) 
are released and dissolve the mineralized bone matrix. Degradation remnants are 
removed from the resorption cavity by endocytosis. Subsequently, the 
endocytosed vesicles are transported to the non bone facing site of the osteoclast 
and relased at the secretory domain [for review see 18]. 
The activation and resorption phase of the remodeling cycle is followed by the so 
called reversal phase. During this phase, yet unknown mononuclear cells clean 
the bone surface. For that reason, remained unmineralized matrix components are 
removed from the resorption lacuna. Possible candidates for this preparation of 
the bone surface are the bone lining cells or osteomacs [16, 20]. Concomitantly, a 
change from osteoclast to osteoblast activity takes place during this stage. 
The formation phase is initiated by the recruitment and activation of the bone 
forming osteoblasts. This may be induced by soluble coupling factors that were 
embedded in the bone matrix and are released during bone degradation, such as 
transforming growth factor-β (TGF-β). Another possibility is the secretion of 
coupling factors by osteoclasts. Candidate molecules are for instance sphingosine 
1-phosphate and ephrin-B2. Upon activation, osteoblasts become cuboidal and 
start to deposit new unmineralized bone matrix (osteoid). The subsequent 
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incorporation of osteoblast derived calcium and phosphate into the osteoid then 
leads to the mineralization of the new bone matrix. 
Osteoblasts synthesize as much bone as osteoclasts had removed during the 
resorption phase. Therefore, the remodeling cycle is terminated when the initial 
amount of bone is reestablished. The bone forming osteoblasts either differentiate 
into fully mature osteocytes, quiescent bone lining cells or undergo apoptosis. 
Finally, the initial state of the bone surface is restored [for review see 20]. 
 
Macrophages 
Macrophages develop from haematopoietic stem cells (HSCs) and are a part of 
the innate and the adaptive immune system. They derive from myeloid progenitor 
cells of the bone marrow that differentiate into circulating blood monocytes. In 
mice and humans, two distinct monocyte populations have been described, 
termed as “inflammatory” and “resident” monocytes [21]. 
Upon an activation stimulus like an infection, injury or inflammation, blood 
monocytes are recruited to the site of issue and differentiate into inflammatory 
macrophages [22]. They can attack, engulf and digest for instance pathogens or 
dying cells (phagocytosis) and subsequently trigger an immune response. 
Moreover, they can present antigens together with MHC molecules on their 
surface and thus activate T-lymphocytes. Next to this, they are also able to secrete 
pro- as well as anti-inflammatory cytokines [23].  
A subset of the circulating monocytes in the blood migrates into the different 
tissues of the body and become so called resident tissue macrophages [22]. This 
macrophage subset together with its progenitors is considered as the mononuclear 
phagocyte system (MPS) [24]. They are present in nearly every tissue of the body 
where they constantly survey their environment. Under pathological conditions, 
they can get activated and participate in the establishment of an immune response 
[51]. Next to this immunological role, they can even take over tissue specific 
functions [22, 25, 26] due to tissue adaption.  
The F4/80 antigen, a surface molecule of the EGF-TM7 receptor family, is mainly 
expressed on mature macrophages [27, 28]. Thus, an antibody against F4/80 can 
be used to visualize murine mature macrophages. 
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Osteomacs 
In bone, these resident tissue macrophages are called osteomacs and can be 
found on the inner and outer surface of the bone. They are a profound cellular 
component of the bone as they make up approximately 1/6 of the total osteogenic 
cells and build up a huge network all over the bone surface [29].  
Moreover, osteomacs are associated with sustaining HSC niches in the bone 
marrow. Depletion of them leads to a disruption of these niches and subsequently 
triggers the recruitment of HSCs into the peripheral blood [30]. Thus, they are 
crucial for the maintenance of hematopoiesis. 
Recently it could be shown that primary osteoblast cultures, that where often used 
as a model system for osteoblasts, were contaminated with these resident 
macrophages [29]. Furthermore, they could prove that lipopolysaccharide (LPS) 
responsiveness in these cultures as well as accurate osteoblast function in vitro 
[29] and in vivo [31] depends on the co-isolated osteomacs. These findings 
suggest important roles of osteomacs in bone biology and make a re-investigation 
of several osteoblast  functions observed in these cultures indispensable. 
Additionally, osteomacs cover active bone modeling [29] as well as bone 
remodeling sites [32]. This close anatomical localization suggests some kind of 
interaction between osteomacs and the other involved bone cells. This hypothesis 
is strengthened by the observation that upon macrophage depletion active 
osteoblasts at bone modeling sites disappear [29]. Furthermore, at bone 
remodeling sites it is proposed that osteoclasts provide some kind of coupling 
signal to activate and coordinate osteoblast function. In contrary, bone formation 
takes place at bone modeling sites despite the lack of a close anatomical contact 
between osteoclasts and osteoblasts. This may be achieved by an osteoclast-like 
support provided by osteomacs. Indeed macrophages develop from the same 
precursor and are also able to produce factors that are thought to be involved in 
osteoblast-osteoclast coupling such as TGFβ [33] and ephrin B2 [34].  
Finally, macrophages are able to secrete a broad range of factors that can act on 
bone forming osteoblasts [35, 33, 36, 37] as well as on bone degrading 
osteoclasts [38, 39, 40, 41, 42]. The ability of the osteomacs to interact with the 
two major players in bone biology makes them potent candidates for participating 
in bone dynamics. 
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Proposed model of the role of osteomacs in bone modeling 
Allison R. Pettit et al. reviewed the potential involvement of osteomacs in the 
dynamic processes in bone [32] and proposed following model for bone modeling: 
 
Figure 7: Proposed involvement of osteomacs in bone modelling. (Adapted from Allison R. Pettit et al. 
2008) 
 
In bone modeling, bone forming osteoblasts act independently from osteoclasts 
and thus reshape the structure of the bone. It is an anabolic process that is not 
coupled to osteoclast-mediated bone degradation.  
Resting bone surfaces are covered by bone lining cells, intercalated osteomacs 
[29] and osteoprogenitors. As illustrated in figure 7, recruitment and proliferation of 
osteomacs is initiated if an anabolic stimulus is sensed by these cells. This may be 
achieved by M-CSF secretion by bone lining cells and osteoprogenitors. In return, 
osteomacs activate osteoblasts followed by the formation of a canopy-like 
structure of osteomacs over the bone modeling site. This leads to a close 
anatomical contact between osteomacs and osteoblasts. Then, osteomacs are 
thought to provide some kind of coupling signal to the osteoblasts that trigger the 
osteoid-secretion and its subsequent mineralization.  
After occurrence of a termination signal or elimination of the anabolic stimuli, the 
initial state of the bone surface is restored. 
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Proposed model of the role of osteomacs in bone remodeling 
Potential participation of osteomacs in bone remodeling, as proposed by Allison R. 
Pettit et al. [32]: 
 
BMU
Figure 8: Potential model how osteomacs participate in bone remodelling. (Adapted from Allison R. Pettit 
et al. 2008) 
 
In contrast to bone modeling, bone remodeling involves a coupled activity of bone 
forming osteoblasts and bone degrading osteoclasts. Therefore, the overall 
amount of bone tissue remains unaltered.  
As indicated in figure 8, bone lining cells as well as osteomacs respond to 
remodeling signals by inducing the secretion of RANKL and M-CSF by 
osteoblasts. These two factors are crucial for the recruitment, survival and 
differentiation of pre-osteoclasts to mature, multinucleated osteoclasts. 
Concomitantly to the initiation of bone resorption, it is assumed that also 
osteomacs proliferate and form the characteristic canopy-structure over the bone 
remodeling site in response to M-CSF. At the leading end of the basic multicellular 
unit (BMU), osteoclasts are thought to serve a coupling signal to osteoblasts that 
lead to their recruitment and activation. On the contrary, they propose that the 
osteomacs at the tail end are responsible for regulating the ongoing osteoid 
secretion and late stage mineralization.  
Again, either a termination signal or the lack of anabolic stimuli leads to the 
restoration of the quiescent bone surface. 
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Cathepsin S 
Cathepsin S is a papain-type cysteine protease that is highly expressed in spleen 
and in major histocompatibility complex (MHC) class II-positive cells such as B 
lymphocytes, macrophages and other professional antigen presenting cells [43, 
44]. 
Cysteine lysosomal proteases play an important role in the processing of intra- 
and extracellular proteins present in endosomes [45]. Furthermore, cathepsin S 
catalyzes the degradation of the invariant chain (li) to CLIP (class II-associated 
invariant chain peptide) and subsequently enables the peptide loading of MHC 
class II molecules [46].  Thus, next to other members of lysosomal proteases, 
cathepsin S is crucial in efficient antigen presentation. 
Moreover, cathepsin S can be actively secreted from activated 
macrophages/microglia, maintains its proteolytic activity also at neutral pH, and is 
able to degrade a number of extracellular matrix (ECM) components in vitro [44, 
47]. Taken together, these findings suggest that cathepsin S could also be 
involved in ECM remodeling.  
In addition, cathepsin S favors the differentiation of mesenchymal stem cells 
(MSCs) to adipocytes [48]. The commitment of MSCs to either the adipocyte or the 
osteoblast lineage seems to be competitive [48, 49]. Thus, alterations of the 
amount of cathepsin S could have an influence on the fat- and bone-phenotype of 
an individual. 
Finally, Cathepsin S knock out mice do not show a severe immunodeficiency, as 
numbers of B cells and T cells are normal [50]. Nevertheless, peptide loading is 
slowed down and germinal center reactions as well as antibody isotype switching 
are only weak or totally absent [50].  
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Hypothesis / Aim of the study 
 
Macrophages develop from myeloid precursors that differentiate into blood 
circulating monocytes. A subset of these monocytes subsequently migrates into 
virtually all tissues of the body where they differentiate into tissue adapted, 
resident tissue macrophages. As cathepsin S is able to participate in ECM 
remodeling and is also expressed in macrophages, a knockout of this protein may 
influence the migration behavior of macrophages. Consequently, we hypothesized 
a reduced number of F4/80+ resident tissue macrophages in osteal tissues in mice 
deficient in cathepsin S. 
 
After reviewing literature about the consequences of the knockout of cathepsin S, 
like for instance slowed down peptide loading, we expected to find a decreased 
MHC class II surface expression on F4/80 positive macrophages.  
 
Preliminary data from our laboratory show that three months old cathepsin S 
deficient mice exhibit a discreet bone phenotype, characterized by a diminished 
bone mineral density. Therefore we speculated that six month old, female  
cathepsin S knockout mice display a decreased bone mineralization. 
 
To investigate these ideas we performed immunofluorescence staining and flow 
cytometry of bone and spleen tissue of catS-/- mice and wild-type mice. To 
examine the bone microarchitecture, micro-computed tomography analyses and 
histomorphometric measurements were performed on decalcified, hematoxylin 
and eosin stained sections.  
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Materials 
 
Reagents 
Accutase PAA, CatNo: L11-007 
Acetic acid 99-100% Merck, CatNo: 818755 
Calcium chloride dihydrate Merck, CatNo: 102382  
Dako-Pen Dako, CatNo: S200230 
DAPI (4'-6-Diamidino-2-phenylindole)  Roche, CatNo: 10236 276 001 
di-Sodium hydrogen phosphate dihydrate Merck, CatNo: 106580 
DMSO Sigma-Aldrich, CatNo: D2650 
Entellan® Merck, CatNo: 107961 
Eosin Y solution Sigma-Aldrich, CatNo: 318906 
Ethanol absolut Prolabo, CatNo: 20821330 
FCS Gold PAA, CatNo: A15-151 
Ficoll-PaqueTM PLUS GE Healthcare, CatNo: 17-1440-03 
Formaldehyde solution Merck, CatNo: 818708 
Fungizone Gibco, CatNo: 04195780 D 
Glycerol 85% Merck, CatNo: 104094  
HBSS Gibco, CatNo: 140259 
Hepes Merck, CatNo: 10110 
Hydrochloric acid 30% Merck, CatNo: 100318  
Hydrochloric acid 37 % VWR, CatNo: 20252.290 
L-Ascorbic acid Sigma-Aldrich, CatNo: A4544 
Mayer's hemalum solution Merck, CatNo: 109249 
Mowiol 4-88 Carl Roth, CatNo: 0713 
Paraffin 52-54 °C Carl Roth, CatNo: CN49.2 
Paraffin 56-58 °C Carl Roth, CatNo: 6642.5 
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Penicillin-Streptomycin Gibco, CatNo: 15140-122 
Potassium chloride Merck, CatNo: 104936  
Potassium dihydrogen phosphate Merck, CatNo: 104872 
Saponin Sigma, CatNo: S-130-2 
Sevorane® Abbott, CatNo: 4456 
Sodium hydroxide Merck, CatNo: 106498 
Titriplex® III Merck, CatNo: 108418  
Triton® X-100 Merck, CatNo: 108603  
Trizma® base Sigma-Aldrich, CatNo: T1503 
Trypsin Sigma-Aldrich, CatNo: T7409 
Xylole Fisher Chemical, CatNo: 10385910 
α-MEM Gibco, CatNo: 22561-021 
β-glycerophosphate  Sigma-Aldrich, CatNo: G9891 
 
 
Sera 
Goat serum Innovative Research, CatNo: IGT-SER 
 
 
Antibodies & Stains 
Primary and direct conjugated antibodies 
- Hamster anti-mouse CD3e PerCP (BD PharmingenTM, CatNo: 553067) 
     monoclonal, clone: 145-2C11, isotype: Armenian Hamster IgG1 κ 
 
- Rat anti-mouse F4/80 (eBioscience, CatNo: 14-4801) 
     monoclonal, clone: BM8, host/isotype: Rat IgG2a, κ 
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- Rat anti-mouse F4/80 PE (eBioscience, CatNo: 12-4801) 
     monoclonal, clone: BM8, host/isotype: Rat IgG2a, κ 
 
- Rat anti-mouse MHC class II FITC (Exbio, CatNo: 1F-621-C100) 
     monoclonal, clone: M5/114, isotype: Rat IgG2b 
 
Secondary antibody 
- Alexa Fluor® 568 goat anti-rat IgG (H+L) (Invitrogen, CatNo: A-11077) 
      isotype: IgG 
 
 
Solutions 
Decalcification solution (Tris/EDTA) 
Add 10 % Titriplex® III and 3.3 % Trizma® base to ddH2O and adjust the pH to 
7.4 with 20 % ammonia. 
 
Eosin Y working solution 
Add 6 % Eosin Y solution and 0.1 % acetic acid (99-100 %) to ddH2O. 
 
Mowiol 
Mix 6 g glycerol with 2.4 g Mowiol 4-88 in a 50ml tube and stir for 1 hour at room 
temperature. Add 6 ml ddH2O and stir for one more hour at room temperature. 
Add 12 ml 0.2 M Tris/HCl (pH 8.5), incubate for up to 3 hours in a 50 °C water bath 
and stir every 20 minutes to dissolve Mowiol. Clarify by centrifugation at 5000 g for 
15 minutes, aliquot the supernatant and store at -20 °C. 
 
Osteogenic medium for cell culture 
Add 5 mM β-glycerophosphate and 50 µg/ml ascorbic acid to standard medium.  
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Permeabilization & blocking buffer (P & E buffer) 
Add 0.1 % Triton X-100 and 10 % goat serum (add prior use) to PBS. 
 
Saponin 
Mix 10 g Saponin and 23.8 g Hepes and fill up to 100 ml with HBSS. Stir over 
night and filter the solution (steril). For usage, dilute 1:100 in PBS. 
 
Standard Medium for cell culture 
Add 10 % FCS Gold (heat-inactivated), 1.1 % Penicillin-Streptomycin and 0.1 % 
Fungizone to α-MEM. 
 
Trypsin working solution (0.1 %) 
Ad 10 % trypsin stock solution (1 %) and 10 % CaCl2 stock solution (1 %) to 
ddH2O, adjust pH to 7.8 with 1 N NaOH and prewarm it to 37 °C prior use. 
 
10 x PBS 
Dissolve 27 mM KCl, 1.37 M NaCl, 15 mM KH2PO4 and 81 mM Na2HPO4·2H2O in 
ddH2O. 
 
1 x PBS 
Dilute the 10 x PBS 1:10 with ddH2O and adjust the pH to 7.4 with 0.1 N NaOH or 
HCl. 
 
1 % HCl-EtOH solution 
Add 3.6 % of 37 % HCl slowly in drops to EtOH absolut. 
 
4 % PFA 
Dilute 37 % formaldehyde solution in PBS. 
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Methods 
 
Animals 
Six months old, female cathepsin S knockout and wild-type mice on a C57BL/6J 
background were used for the experiments. Cathepsin S deficient mice were 
kindly donated by Prof. Shi (Brigham and Women’s hospital, Boston, MA) and 
were breeded according to the Austrian laws and institutional regulations at the 
Medical University of Vienna, Core Unit of Biomedical Research, Division of 
Laboratory Animal Science and Genetics. Mice were narcotized using Sevorane® 
and sacrificed by cervical dislocation. 
 
Paraffin embedding 
To prepare the isolated vertebral columns for paraffin-embedding, they were cut in 
shape of maximal 0.5 x 2 x 1 cm (height x length x width) and fixed in 4 % PFA for 
24 hours at 4 °C, with a medium change in-between. The bone of the vertebral 
columns was decalcified in decalcification solution (Tris/EDTA) for 5 days at 4 °C 
with daily solution changes in-between and subsequently washed with ddH2O to 
remove precipitated salts. The tissue was dehydrated in an increasing alcohol 
series (50 %, 70 %, 96 %, 96 % EtOH and twice EtOH absolute, each step for      
1 hour at room temperature) and a final incubation in xylole at 4 °C over night. For 
optimal infiltration of the embedding material, the biopsies were placed in three 
different 60 °C warm baths of paraffin (melting point 52-54 °C) for 15, 15 and 30 
minutes and at the end in 60 °C warm paraffin (melting point 56-58 °C) for 120 
minutes. Final embedding was performed using a tissue embedding system     
TES 99 (MEDITE, Burgdorf, Germany). 
 
Sectioning 
Using a sledge microtome HM 400R (MICROM International, Walldorf, Germany), 
4 µm thick sections were cut, placed on Superfrost® Microscope slides (Thermo 
Scientific, Menzel-Gläser, CatNo: J4800AMNZ) and dried for 2 days at 37 °C. 
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Immunohistochemistry 
All sections were examined using a Carl Zeiss Axioplan 2 microscope (Carl Zeiss 
Microscopy, Göttingen, Germany). 
 
- Hematoxylin and eosin staining 
 
Paraffin embedded sections were dewaxed in xylole for two times 10 minutes, 
rehydrated by a decreasing alcohol series (EtOH absolut, 96 %, 70 % and 50 %, 
each step 5 minutes) and rinsed with ddH2O. Specimens were stained in Mayer’s 
Hemalum solution for 10 minutes and washed in ddH2O for 5 minutes. Sections 
were differentiated in 1 % HCl-EtOH solution for 5 minutes and washed under 
running tap water for 10 minutes. Counterstaining was performed by incubation of 
the tissue for 20 seconds with Eosin Y working solution with a subsequent 
washing step in ddH2O for 5 minutes. Slides were dehydrated through 96 % EtOH, 
EtOH absolut and xylole (each step two times 5 minutes) and mounted with 
Entellan®. 
 
- Immunofluorescence staining for F4/80 
 
For optimal attachment of the tissue to the microscope slides, they were baked for 
25 minutes at 60 °C. Specimens were dewaxed and rehydrated as described 
above. Antigen retrieval was achieved by incubating the sections for 10 minutes 
with freshly made 37 °C warm 0.1 % trypsin solution. To stop the enzymatic 
reaction, the slides were placed under running water for 3 minutes. Sections were 
washed three times for 5 minutes in PBS and afterwards rinsed with ddH2O 
between each step. The amount of required reagents was minimized by drawing a 
hydrophobic circle with the Dako Pen around the tissue. Sections were 
permeabilized and blocked in P & E buffer for 30 minutes at room temperature, 
followed immediately without washing in-between by primary antibody incubation 
(rat anti-mouse F4/80, 1 µg/ml in P & E buffer) in a humidifier chamber at   4 °C 
over night. The Alexa Fluor® 568 conjugated secondary antibody (0.5 µg/ml in     
P & E buffer) was applied for one hour at room temperature and nuclei were 
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stained using DAPI (1 mg/ml in PBS) for 15 minutes. Slides were mounted with 
Mowiol and coverslipped. 
 
Cell culture 
For establishment of the spleen cell culture, spleens were isolated and 
homogenized by grinding the tissue through a sieve in 10 ml standard medium. 
Bone marrow (BM) cells were isolated by cutting off the ends of the femora and 
tibiae and flushing the bone marrow with 10 ml standard medium using a 0.5 mm 
gauge needle.  
Osteoblast cell culture: Three million BM cells were transferred into a 12-well plate 
and put into the incubator (37 °C, 95 % air humidity and 5 % CO2). Medium was 
changed beginning with day 5 every 2 days using osteogenic medium for cell 
culture. This medium additionally contained β-glycerophosphate and ascorbic acid, 
which induced the differentiation of the mesenchymal stem cells (MSCs) in the 
direction of osteoblasts. 
Bone marrow/spleen cell culture: 15 ml Ficoll-PaqueTM PLUS were layered with 
spleen or BM cells without mixing and subsequently centrifuged for 30 minutes at 
room temperature at 1500 rpm without brake. The white ring between the plasma 
and the Ficoll-PaqueTM PLUS that contains the mononuclear cells was carefully 
isolated and transferred into a 50 ml falcon tube. Then the cells were washed in 
HBSS by centrifuging them for 10 minutes at room temperature at 1500 rpm and 
the pellet was resuspended in 10 ml standard medium. Cells were placed in a 6-
well plate and put into the incubator (37 °C,     95 % air humidity and 5 % CO2) for 
4 hours. 
 
Flow cytometry 
Bone marrow/Spleen cells: After the isolation of mononuclear cells as described 
above, cells were harvested using a plastic scratch, washed as mentioned before 
in PBS and fixed in 2 % PFA for 20 minutes at room temperature protected from 
light. Then they were centrifuged for 10 minutes at room temperature at 1500 rpm 
and pellets were resuspended and washed in PBS. After resuspension of the 
pellet in PBS, cells can be stored at 4 °C. For measurement, samples were 
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transferred to 1.4 ml ScreenMates tubes (Thermo Scientific), centrifuged for 10 
minutes at room temperature at 1500 rpm and pellets were resuspended in 0.1 % 
saponin buffer for membrane permeabilization. Cells were centrifuged and 
subsequently resuspended in 50 µl antibody dilution (anti-CD3 1:100, anti-F4-80 
1:100, anti-MHC II 1:20 diluted in 0.1 % saponin buffer) and incubated for 25 
minutes at room temperature protected from light. After another washing step in 
0.1 % saponin buffer, cells were resuspended in 250 µl PBS and measured using 
the BD FACSCaliburTM flow cytometer (BD Biosciences). 
Osteoblast culture: On day 12, osteoblasts were washed in PBS and detached 
using 500 µl accutase for 4 minutes at 37 °C. Subsequently cells were harvested 
using a plastic scratch and transferred to a 15 ml falcon tube. After centrifugation 
for 10 minutes at room temperature at 1500 rpm, the pellets were resuspended in 
1 ml PBS, transferred to 1.4 ml ScreenMates tubes (Thermo Scientific) and 
centrifuged. Cells were stained with anti-F4/80-PE (1:100, diluted in PBS) and 
incubated for 20 minutes protected from light. After an additional washing step in 
PBS, the pellet was resuspended in 350 µl PBS and measured using the BD 
FACSCaliburTM flow cytometer (BD Biosciences, California, USA). 
 
Micro-computed tomography 
Vertebral columns were isolated and the fifth lumbar vertebra was measured in   
70 % EtOH using the Scanco Medical µ-CT 35 (SCANCO Medical, Brüttisellen, 
Switzerland). In case of an inadvertent destruction of the fifth lumbar vertebra, the 
fourth one was used. Trabecular and cortical bone were analyzed independently 
from each other. Bone structures of interest were traced manually with the 
computer mouse. From each sample 231 slices were used for the calculation of 
the bone parameters.  
 
Histomorphometry 
The fifth lumbar vertebra was analyzed in HE stained sections using the 
OsteoMeasurexpTM (OsteoMetrics, Decatur, GA, USA). In case of an inadvertent 
destruction of the fifth lumbar vertebra, the fourth one was used. Sections were 
examined with 10x magnification on a light microscope that is connected to a 
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computer with the image analysis software. The borders of the trabeculae and 
osteocyte lacunae were manually traced with a pen on the digitized drawing tablet. 
Osteocyte lacunae were examined using the “void”-function of the software. 
Cortical bone and artifacts were excluded.  
 
 
 
Statistical Analysis 
Statistical analyses were performed using a one-sided Mann-Whitney-Test.          
P-values ≤ 0.05 were considered as statistically significant. All results are 
represented as mean value ± standard deviation.   
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Results 
 
Visualization of F4/80 positive cells 
Osteomacs, the osteal resident tissue macrophages, are present in a high number 
in murine and human bone tissue. Due to tissue adaption they fulfill next to global, 
immunological functions additionally tissue specific ones. Figure 9 shows the 
periosteum that lines the external surface of the vertebral body. Here the 
osteomacs are intercalated amongst bone lining cells and osteogenic progenitor 
cells [3, 29]. For the visualization of these osteomacs in the vertebral column of 
cathepsin S knockout and wild-type mice, we used immunofluorescence stainings. 
 
 
 
Figure 9: HE staining of the fifth lumbar vertebrae of an OF-1 mouse showing the periosteum (white 
arrow; original magnification: 10x). Spines were prepared as described in Figures 2 and 3. Cytoplasm and 
mineralized bone matrix occurs in red, nuclei in purple. 
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Figure 10: Osteomacs are present in the periosteum of cathepsin S knockout and wild-type mice 
(original magnification: 10x). A-E, Immunofluorescence staining of paraffin-embedded vertebral columns of 
cathepsin S knockout (A-B) and wild-type (C-D) mice. Osteal macrophages were stained with anti-F4/80 (red), 
nuclei with DAPI (blue). Picture E shows the negative control without primary antibody application. 
 
Microscopic inspection did not reveal any visible differences between cathepsin S 
knockout and wild-type mice. The osteomacs were present in the periosteum 
(Figure 10, A-D) as well as on the inner bone surface lining the trabeculae. Neither 
the number nor the distribution and morphology of the osteomacs were changed in 
the knockout mice (A-B) compared to wild-type mice (C-D). Consistent with these 
findings, flow cytometry analysis of bone marrow cultures showed similar numbers 
of F4/80+ cells in both mouse genotypes, as shown in table 1. Also in the splenic 
cell cultures no significant differences in the number of F4/80+ cells were 
detectable. 
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Table 1: F4/80 expression in bone marrow cultures analyzed by flow cytometry. 
Parameter Wild-type 
(n = 3) 
Knockout 
(n = 3) 
p-value 
Bone marrow    
F4/80+ cells [%] 4.6 ± 1.2 4.9 ± 1.8 n.s. 
Spleen    
F4/80+ cells [%] 11.0 ± 3.2 6.6 ± 1.1 n.s. 
 
Coisolated osteomacs in osteoblast cultures 
Recently, F4/80+ macrophages were detected in primary osteoblast cultures 
derived from neonatal rodent calvaria [29]. Using flow cytometry, we proved that 
this co-isolation also occurs in osteoblast cultures harvested from the bone 
marrow of 6 month old mice.   
 
A 
 
 
B 
Figure 11: Flow cytometry analysis of 12 days primary osteoblast cultures from cathepsin S knockout 
(A) and wild-type (B) mice. Samples were stained with anti-F4/80-PE. Unstained negative controls (upper 
panel) were used to separate the F4/80 signal from autofluorescence. The number in the right corner 
represents the percentage of F4/80 positive cells in the cell culture.  
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As shown in Table 2, no statistically significant alteration in the portion of F4/80+ 
cells was observed. However, there was a trend in the osteoblast cultures of 
cathepsin S knockout mice towards an increased number of F4/80+ cells on day 
12. The mean fluorescence intensity of F4/80 stained cells showed no relevant 
differences.  
 
Table 2: F4/80 expression in 12 days osteoblast cultures analyzed by flow cytometry.   
Parameter Wild-type 
(n = 3) 
Knockout 
(n = 3) 
p-value 
F4/80+ cells [%] 56.3 ± 6.4 69.1 ± 3.0 n.s. 
MFI F4/80 [mfi] 536 ± 133 842 ± 435 n.s. 
  MFI = mean fluorescence intensity 
 
 
Investigation of MHC II expression  
Cathepsin S plays an important role in the presentation of antigens. It not only 
degrades proteins for this purpose, it also enables the subsequent loading of  
MHC II molecules on the surface of antigen presenting cells. As macrophages also 
express this molecule, we wanted to investigate if the lack of this lysosomal 
protease has an influence on the MHC II expression of osteomacs. For this 
purpose, cell cultures of the spleen and the bone marrow of cathepsin S knockout 
and wild-type mice were established. After fixation, permeabilization and staining 
of the cells, flow cytometry analyses were performed. Macrophages were gated 
using the FSC (Forward Scatter) versus SSC (Sideward Scatter) pattern and their 
positivity for F4/80.  
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Figure 12: Dot plot of macrophages of a bone marrow culture from a cathepsin S knockout mouse. The 
upper right quadrant shows events that are positive for F4/80 and MHC II.  
 
Table 3 illustrates that there was no difference in the number of MHC II expressing 
F4/80+ macrophages and in the intensity of the MHC II signal between cathepsin S 
knockout and wild-type mice. However, catS-/- cells of both cell cultures revealed a 
trend towards an increased mean fluorescence intensity of the MHC II signal.  
 
Table 3: MHC II expression of macrophages in spleen and bone marrow cell cultures analyzed by flow 
cytometry.  
Parameter Wild-type 
(n = 3) 
Knockout 
(n = 3) 
p-value 
Bone marrow    
MHC II [%] 86.4 ± 6.5 83.4 ± 3.4 n.s. 
MFI MHC II [mfi] 18.4 ± 1.2 33.1 ± 11.1 n.s. 
Spleen    
MCH II [%] 81.7 ± 4.5 83.8 ± 4.6 n.s. 
MFI MHC II [mfi] 37.2 ± 3.4 46.2 ± 4.2 n.s. 
  MFI = mean fluorescence intensity 
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Moreover, we could see two distinct subpopulations in the dot plot of mononuclear 
cells of the bone marrow cell culture (Figure 13, A). Both populations revealed a 
similar SSC pattern, a measurement for the granularity of cells. Nevertheless, they 
can be distinguished by their size as their FSC pattern differs from each other. In 
figure 13, B is shown that the smaller cells express less MHC II. As a result, we 
call them MHC IIlow and the larger cells MHC IIhigh. 
 
A B 
R1 
C 
Figure 13: Bone marrow cell cultures contain two subpopulations that differ in size and mean 
fluorescence intensity of MHC II. A, Dot plot of the mononuclear cells of a bone marrow cell culture of a 
cathepsin S knockout mouse. Macrophages were defined as “not R1” and further separated into MHC IIlow 
(R2) and MHC IIhigh (R3) according to their size (A) and their MHC II signal (B). C, Histograms showing the 
percentage of each cell population and the mean fluorescence intensity of the MHC II signal.  
 
- 33 - 
Table 4 demonstrates that neither the number nor the intensity of the MHC II 
signal of the MHC IIlow population differs between cathepsin S knockout and wild-
type mice. On the contrary, there was a significant decrease in MHC IIhigh cells in 
the catS-/- mice. Furthermore, we observed a higher mean fluorescence intensity 
of the MHC II signal in these mice. 
 
Table 4: Percentage and MHC II intensity of the two macrophage subpopulations in bone marrow cell 
culture analyzed by flow cytometry. 
Parameter Wild-type 
(n = 3) 
Knockout 
(n = 3) 
p-value 
MHC IIhigh [%] 2.89 ± 0.18 2.33 ± 0.15 0.050 
MHC IIlow [%] 3.16 ± 0.99 3.61 ± 1.93 n.s. 
MFI MHC IIhigh [mfi] 23.33 ± 0.77 47.99 ± 3.83 n.s. 
MFI MHC IIlow [mfi] 8.83 ± 0.73 10.62 ± 2.39 n.s. 
  MFI = mean fluorescence intensity 
 
Alteration in bone microarchitecture 
Cathepsin S is associated with the differentiation of mesenchymal stem cells 
(MSCs). As bone forming osteoblasts develop from MSCs, we wanted to 
investigate if cathepsin S deficiency has an effect on the microarchitecture of the 
bone tissue of murine vertebral columns. Therefore, we examined bone 
microarchitecture using x-ray based micro-computed tomography. The µ-CT 
scanned individual slices of an object and assembled a 3D model by laying one 
slice over each other. The software then analyzed the data and calculated several 
bone parameters. 
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Trabecular bone: 
 
Figure 14: Manual selection of the trabecular structures of a vertebral body. The µ-CT scanned 231 
slices of the vertebral body and assembled a 3D model of it. For evaluation of the trabecular bone parameters, 
the trabecular structures had to be selected manually on the computer.  
 
 
Table 5 illustrates the µ-CT derived bone parameters of the trabecular bone 
structures of the fifth or fourth vertebral body of cathepsin S knockout and wild-
type mice. The connectivity density gives the number of trabecular connections 
per mm3. This parameter was significantly increased in the knockout mice. 
Furthermore, a decrease in trabecular thickness was observed in these mice. 
Moreover, the tissue bone mineral density (TissBMD) parameter was decreased in 
knockout mice compared to their wild-type littermates. This parameter is a 
measure for the level of mineralization as it represents the hydroxyapatite content 
of the bone.  
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Table 5: Trabecular bone parameters 
Parameter Wild-type 
(n = 6) 
Knockout 
(n = 6) 
p-value 
BV/TV [%] 0.23 ± 0.06 0.23 ± 0.03 n.s. 
Conn. dens. [1/mm3] 356 ± 271 666 ± 254 0.047 
Tb.N [1/mm] 5.8 ± 1.4 5.4 ± 1.2 n.s. 
Tb.Th [mm] 0.044 ± 0.004 0.038 ± 0.003 0.013 
Tb.Sp [mm] 0.20 ± 0.06 0.21 ± 0.04 n.s. 
AppBMD [mg HA/ccm] 238 ± 58 223 ± 44 n.s. 
TissBMD [mg HA/ccm] 949 ± 18 915 ± 44 0.032 
BV = bone volume; TV = tissue volume; Conn.dens = connectivity density; Tb.N = trabecular number; Tb.Th = 
trabecular thickness; Tb.Sp = trabecular separation; AppBMD = apparent bone mineral density; TissBMD = 
tissue bone mineral density; HA = hydroxyapatite 
 
 
Cortical bone: 
 
Figure 15: Manual selection of the cortical structures of a vertebral body. The µ-CT built up a 3D model 
of the vertebral body out of 231 scanned slices. The cortex was selected by manually tracing the borders of it 
on the computer.  
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Data of the µ-CT measurements of the cortex are demonstrated in table 6. The 
values of apparent bone mineral density (AppBMD) and tissue bone mineral 
density (TissBMD) were significantly decreased in cathepsin S knockout mice. 
Both parameters represent the hydroxyapatite density and therefore the level of 
mineralization. Apparent bone mineral density refers to bone and background, 
tissue bone mineral density only to bone.   
 
 
Table 6: Cortical bone parameters 
Parameter Wild-type 
(n = 5) 
Knockout 
(n = 6) 
p-value 
BV/TV [%] 0.88 ± 0.01 0.85 ± 0.04 n.s. 
AppBMD [mg HA/ccm] 869 ± 22 817 ± 54 0.041 
TissBMD [mg HA/ccm] 980 ± 16 941 ± 56 0.041 
BV = bone volume; TV = tissue volume; AppBMD = apparent bone mineral density; TissBMD = tissue bone 
mineral density; HA = hydroxyapatite 
 
 
Examination of osteocyte lacunae 
A second technique to evaluate bone microarchitecture is bone histomorphometry. 
This 2D based technique uses stained sections of the tissue of interest. Then, 
tissue structures have to be manually traced on a computer drawing tablet. 
Several bone parameters as well as characteristics of osteocyte lacunae were 
calculated by the OsteoMeasurexpTM software. 
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Figure 16: Overview of a lumbar vertebra of a cathepsin S wild-type mouse after manual examination. 
Trabecular bone is bordered in blue, osteocyte lacunae in red and artefacts (non tissue) in grey. 
 
 
Figure 17: Overview of a lumbar vertebra of a cathepsin S knockout mouse after manual examination. 
Trabecular bone is bordered in blue, osteocyte lacunae in red and artefacts (non tissue) in grey. 
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Table 7 illustrates that there was a significant decrease in osteocyte lacuna 
volume to bone as well as tissue volume in knockout mice. Also the relationship of 
osteocyte lacuna surface to bone surface declined in the cathepsin S knockout 
compared to wild-type mice.  
 
Table 7: Trabecular bone parameters, analyzed by bone histomorphometry 
Parameter 
Wild-type 
(n = 3) 
Knockout 
(n = 3) 
p-value 
BV/TV [%] 19.7 ± 1.9 25.2 ± 3.5 n.s. 
Ol.V/TV [%] 0.65 ± 0.02 0.44 ± 0.06 0.050 
Ma.V/TV [%] 80.9 ± 1.9 75.3 ± 3.4 n.s. 
BS/TV [mm2/mm3] 19.6 ± 1.1 18.9 ± 1.5 n.s. 
BS/BV [mm2/mm3] 69.4 ± 42.7 75.4 ± 4.6 n.s. 
Ol.S/BS [%] 38.0 ± 1.8 30.2 ± 1.1 0.050 
Ol.V/BV [%] 3.31 ± 0.42 1.76 ± 0.02 0.050 
Tb.Th [µm] 19.5 ± 2.0 26.1 ± 1.6 n.s. 
Ol.Th [µm] 1.75 ± 0.19 1.56 ± 0.17 n.s. 
Tb.Sp [µm] 82.7 ± 5.6 80.2 ± 10.3 n.s. 
Tb.N [1/mm] 9.8 ± 0.6 9.4 ± 0.8 n.s. 
BV = bone volume; TV = tissue volume; Ol.V = osteocyte lacuna volume; Ma.V = marrow volume; BS = bone 
surface; Ol.S = osteocyte lacuna surface; Tb.Th = trabecular thickness; Ol.Th = osteocyte lacuna thickness; 
Tb.Sp = trabecular separation; Tb.N = trabecular number 
 
Figure 18 showes pictures of HE stained sections of three wild-type and two 
cathepsin S knockout mice. Microscopic inspection indicated that the number of 
osteocytes in the catS-/- mice was diminished compared to wild-type mice. 
Moreover, the osteocyte lacunae appeared to be less in size. These observations 
were consistent with the histomorphometric results.  
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Figure 18: Osteocyte density and lacunae size in a HE stained section of cathepsin S knockout (A-C) 
and wild-type (D-F) mice (original magnification: 10x). Microscopic inspection confirmed the 
histomorphometric data about the decreased osteocyte lacunae volume in cathepsin S knockout mice. 
Moreover, the osteocyte lacunae appeared to be less numerous in these mice.  
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Discussion 
Osteoimmunology is an emerging research field that focuses on the interactions 
between bone and the immune system [10]. Bone harbors the bone marrow and 
therefore provides the place for haematopoiesis [1, 30]. Thus it is crucial for the 
development of the cells of the immune system. On the other side, immune cells 
play important roles in bone biology under physiological as well as pathological 
conditions. One example for osteoactive immune cells are osteomacs, the resident 
tissue macrophages of the bone. Under physiological conditions, they support 
bone forming osteoblasts [29, 32]. Next to this participation in bone dynamics, they 
are activated by inflammatory or infectious stimuli [51]. Then they fulfill 
immunological functions and are able to trigger immune responses.  
In the present study, we investigated the influence of cathepsin S deficiency on the 
presence, distribution, number and MHC class II expression of osteomacs/bone 
marrow macrophages. For this purpose, immunofluorescence stainings and flow 
cytometry analyses were performed. Moreover, bone microarchitecture was 
evaluated with two different techniques, µ-CT and bone histomorphometry.  
 
Presence and distribution of osteomacs 
To visualize osteomacs in the spine of wild-type and cathepsin S knockout mice, 
immunofluorescence stainings with a monoclonal antibody against F4/80 [27, 28] 
were performed. Since this surface molecule is expressed on all murine mature 
macrophages, also inflammatory macrophages can appear positive for F4/80. 
However, the localization and morphology of the stained cells in our experiments 
suggested that these cells belong to the resident tissue macrophage population.  
They were present in both mouse genotypes and displayed a similar distribution 
as well as morphological characteristics. The intercalation throughout the entire 
periosteum demonstrated that osteomacs are a profound cellular component of 
the bone tissue of murine vertebral columns. Moreover, they could be found on the 
inner bone lining layer covering the trabeculae as well as in the bone marrow. As 
shown by others [30], there they fulfill essential functions in the maintenance of the 
haematopoietic stem cell niches. 
Also on a morphological level no visible differences between wild-type and 
cathepsin S knockout mice were observed. The F4/80 positive cells displayed an 
- 41 - 
elongated cell body with processes reaching into their local environment. This 
stellate morphology together with their high number may enable the establishment 
of a broad network covering the whole outer bone surface. Consistent with this, 
the observations from Chang et al. [29] on endosteal surfaces also indicated the 
formation of a comprehensive network by osteomacs. 
As osteomacs are required for adequate osteoblast function, they can be found in 
bone tissue at sites of bone formation. There they envelope active, cuboidal 
osteoblasts [29, 32]. Since only a small portion of the total bone tissue gets 
remodeled at one time point, this may not be the only reason for the extensive 
occurrence of osteomacs on the entire bone surface.  
Another possible explanation for the high number and connectivity of osteomacs 
on periosteal and endosteal surfaced could be their role in immune surveillance. 
Analog to other resident tissue macrophage populations, like for instance the 
microglia in the brain and spinal cord [25], they may act as an immunological 
guard. For that reason, they scan constantly their local environment to quickly 
respond to pathological changes or inflammatory stimuli. Indeed, osteomacs were 
shown to respond to lipopolysaccharide (LPS) [29], a bacterial component that is 
able to trigger a strong immune response. 
Taken together, osteomacs are clearly a profound component of the murine 
vertebral bone tissue. They fulfill tissue adapted physiological functions and 
additionally play an important role in immunological monitoring of bone tissue. 
 
Number of osteomacs / bone marrow macrophages 
Quantitative statements using immunofluorescence stainings are rather subjective. 
Therefore, we performed flow cytometry analyses to determine possible 
differences in the number of F4/80 positive cells between wild-type and cathepsin 
S knockout mice.  
In the mononuclear cell fraction of splenic and bone marrow derived cell cultures, 
no statistically significant alterations in the number of F4/80 positive macrophages 
were observed.  
As shown by Chang et al. [29], F4/80 positive macrophages can be co-isolated 
during the preparation of primary osteoblast cultures obtained from neonatal 
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rodent calvaria. Also in our cell culture preparations, harvested from flushed out 
bone marrow of murine femora and tibiae, F4/80 positive cells were present. 
Indeed, macrophage survival is dependent on M-CSF and osteoblasts are able to 
produce this factor [52]. Contradictory to the findings in the two other cell cultures, 
we could surprisingly see a non significant but distinct increase in the relative 
amount of F4/80 stained cells in the osteoblast cultures of cathepsin S knockout 
mice. Hence, there was a reciprocal reduction in the relative fraction of osteoblasts 
in the cathepsin S knockout cultures.  
This finding would be in line with the µ-CT derived data, where we observed a 
diminished mineralization level of the bone tissue. As osteoid production and its 
subsequent mineralization is both carried out by active osteoblasts, less 
mineralized bone tissue indicates a dysfunction or absence of active osteoblasts. 
Therefore both, the reduced osteoblast number in the osteoblast cultures and the 
reduced mineralization state could be the outcome of an osteoblastic insufficiency 
in cathepsin S knock-out mice.  
 
MHC class II expression 
Macrophages are immunologically active cells that belong to the group of 
professional antigen presenting cells. Cathepsin S is involved in two major steps of 
antigen presentation. Next to other lysosomal acidic proteins it helps to degrade 
the engulfed extracellular material [45]. Additionally, cathepsin S enables the 
loading of MHC class II molecules by cleaving the peptide-binding cleft blocking 
molecule [46]. To examine, if the knockout of cathepsin S influences MHC class II 
surface expression, flow cytometry analyses of osteoblast, spleen and bone 
marrow derived cell cultures were performed. 
In none of the three cell culture systems a significant alteration of the number of 
MHC class II expressing macrophages could be observed. In the descriptive 
statistical analysis the mean fluorescence intensity (MFI) of the MHC class II 
signal on macrophages in the catS-/- derived cell cultures was much higher than in 
the wild-type mice. Nevertheless, due to the chosen one-sided statistical method 
no statistical significance was observed. An increase in MHC class II expression 
despite an unchanged cell number indicated a MHC class II upregulating 
mechanism in cathepsin S knockout mice.  
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MHC class II expression is controlled in a strict manner, solely on a transcriptional 
level. It is expressed constitutively on professional antigen presenting cells such 
as macrophages, B-lymphocytes or dencritic cells. The expression of MHC class II 
molecules can be upregulated or even induced in MHC class II negative cells by 
cytokines, like for instance IFN-γ. This is achieved by the activation of class II, 
major histocompatibility complex, transactivator (CIITA). This positive regulator of 
MHC class II can be transcriptionally activated by IFN-γ, LPS, IL-4 or distinct 
differentiation factors. These factors act on one of the four promoters of the CIITA 
encoding gene (MHC2TA) what subsequently results in CIITA expression. CIITA 
itself binds to the enhanceosome of MHC class II and acts as a transcriptional 
coactivator [for review see 53]. Thus, activation of CIITA by for instance 
inflammatory cytokines can lead to an upregulation of MHC class II surface 
expression. 
Indeed, unpublished data from our laboratory demonstrating an elevation of acute-
phase serum amyloid A suggest that in the cathepsin S knockout mice a mild 
inflammation is present. This apolipoprotein is a rapidly responding reactant that is 
secreted during the early phase of inflammation [54]. As inflammatory conditions 
trigger the synthesis and release of several cytokines, this may explain the 
upregulation of MHC class II molecules on the surface of F4/80 positive 
macrophages.  
Moreover, we found two distinct subpopulations in the bone marrow derived cell 
cultures of wild-type and cathepsin S knockout mice. These subpopulations 
differed in size and MHC class II expression. The smaller cells expressed less 
MHC class II and were therefore called MHC IIlow. Consistent with this 
nomenclature, the larger and more MHC class II expressing cells were termed 
MHC IIhigh. The existence of a MHC IIlow and MHC IIhigh macrophage subset has 
already been desribed in other tissues [55]. The latter ones may represent 
immunologically activated macrophages, as they rise in size when they 
phagocytose material and increase their MHC class II expression for efficient 
antigen presentation. Both can be induced by the presence of IFN-γ, as this type II 
interferon is able to act on macrophages by increasing antigen presentation and 
lysosomal activity [56]. The number of this MHC IIhigh cells decreased in a 
significant manner in mice lacking cathepsin S. In line with our original hypothesis, 
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this finding indicates that there is an inherent defect in catS-/- mice concerning 
MHC IIhigh expressing macrophages.  
Moreover, it could also be possible that there is a kind of a compensatory 
mechanism by which the MHC IIhigh cells try to balance their diminished number 
with increased surface expression of MHC class II molecules. 
 
Bone microarchitecture 
For the evaluation of the bone microarchitecture, murine vertebral bodies were 
examined by two different methods. On the one hand, we used X-ray based µ-CT 
analysis. It is a fast and non-destructive method that assembles a 3D model of the 
sample out of a number of scanned slices. Bone parameters are then directly 
calculated by the µ-CT software. To investigate the bone microarchitecture on a 
microscopic level, we additionally performed histomorphometric measurements of 
decalcified, hematoxylin and eosin stained sections.  
Bone consists of two different compartments: cortical bone on the outside and 
trabecular bone that makes up the interior and harbors the bone marrow [1].  µ-CT 
measurements of the trabecular bone revealed a significantly decreased tissue 
bone mineral density (TissBMD) in cathepsin S knockout mice compared to the 
wild-type mice. This parameter gives the mineralization degree of the bone by 
examining the hydroxyapatite density of the bone tissue. Moreover, the thickness 
of the trabeculae was diminished in the knockout mice while the number of 
trabecular connections per mm3 increased in a significant manner.  
Also the cortical µ-CT derived results showed a significant decrease in tissue as 
well as apparent bone mineral density (AppBMD) in the knockout mice. Both 
parameters describe the level of mineralization of bone. While AppBMD 
represents the hydroxyapatite density in relation to bone and background, 
TissBMD only refers to bone. The decreased AppBMD may suggest that in 
cathepsin S deficient mice intracortical porosity is increased. This age-related 
alteration in cortical bone microarchitecture has a major impact on the mechanical 
properties of bone. Thus it is a crucial risk factor for microdamages and 
subsequently fractures [57]. 
Data from the histomorphometric measurements support the picture of an 
impaired bone phenotype. With bone histomorphometry is was possible to assess 
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individual osteocyte lacuna. Compared to wild-type mice, there was a significant 
decrease in the overall volume of the osteocyte lacunae. Microscopic inspection of 
HE stained sections strengthened these observations and additionally gave the 
impression of a diminished number of osteocytes (Figure 18).  
Taken together, the trabecular as well as cortical µ-CT derived findings indicated 
that cathepsin S knockout mice display a discreet bone phenotype with less 
mineralized bone tissue and thinner trabeculae. In addition, data from bone 
histomorphometry showed a decline in osteocyte lacunae size and number. 
The mineralization of new bone matrix is catalyzed by active osteoblasts. Possible 
reasons for a diminished mineralization could be the absence or reduction of the 
number of osteoblasts or an impaired osteoblastic activity. Osteomacs are crucial 
for adequate osteoblast function and their removal leads to the disappearance of 
active osteoblasts at bone modeling sites [29]. If there is a negative influence of 
cathepsin S deficiency on osteomacs, their supportive effect on osteoblasts could 
be inhibited. Since osteomacs are resident immune surveillants, inflammatory or 
infectious stimuli could trigger a shift from the resident physiological phenotype to 
an immunologically active one. Indeed, as mentioned before there is an ongoing, 
mild inflammation in mice lacking cathepsin S. Therefore, an immunological 
activation of resident tissue macrophages may cause a reduction in the support of 
bone forming osteoblasts by osteomacs. Consequently, less osteoblasts get 
activated, engulfed and finally differentiated into mature osteocytes. This 
hypothesis would be in line with our findings, of a less mineralized bone tissue and 
the reduction of osteocyte lacunae size and number. 
 
Strengths and limitations 
Our work has several strengths and limitations. 
The study was performed in an in vivo model of cathepsin S deficiency. In contrast 
to the knock-down technology, where genes are only partially shutdown, it is here 
possible to completely turn off a gene in an organism. Therefore influences of a 
remaining portion of the gene product are prevented. Moreover, two different 
technologies for the evaluation of the bone microarchitecture were used.  
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One limitation of the present study was the relatively small population size. 
Furthermore, the application of additional marker in immunofluorescence stainings 
and flow cytometry measurements would allow a more precise distinction between 
the inflammatory and resident tissue macrophage populations and an improved 
assessment of the role of osteomacs in the pathogenesis of osteoblast 
dysfunction. To further investigate the influence of the cathepsin S deficiency on 
the number of active osteoblasts, additional histomorphometric analyses have to 
be performed. 
 
Conclusion 
Taken together, cathepsin S deficiency led to a discreet bone phenotype that is 
mainly characterized by a diminished bone mineralization. Additionally, we found 
an inherent effect on the MHC IIhigh macrophage subpolulation, as they displayed a 
decreased number together with an increased MHC class II surface expression. 
As a result, we hypothesize the following role of cathepsin S and osteomacs in the 
establishment of this phenotype: 
Cathepsin S deficiency causes a mild, ongoing inflammation. This inflammatory 
state leads to the recruitment of circulating blood monocytes that differentiate into 
activated, inflammatory macrophages. Concomitantly, also resident tissue 
macrophages are activated by the inflammatory stimuli. Therefore, they change 
their resident phenotype towards the inflammatory one and start to fulfill 
immunological functions such as antigen presentation. Subsequently, the support 
of bone forming osteoblasts is drastically reduced. This lack of support leads to 
less active, bone forming osteoblasts and therefore to a declined number of 
osteocytes incorporated in the bone tissue. Consequently, the bone tissue of mice 
lacking cathepsin S is less mineralized. 
Moreover, cathepsin S may influence the early differentiation of mesenchymal 
stem cells (MSCs). It is proven that cathepsin S deficiency causes a decrease in 
the differentiation towards the adipocyte lineage [58, 59]. If there is also a direct 
influence on the development of osteoblasts has to be further investigated.  
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Figure 19: Proposed model of the role of cathepsin S in bone biology. Mesenchymal stem cells (MSCs) 
can differentiate into various cell types. Osteoblasts are the cells responsible for bone formation. This process 
is supported by the resident tissue macrophage population of the bone, the so called osteomacs. In mice 
lacking cathepsin S (catS-/-), there may be a negative influence on the early differentiation of MSCs to 
progenitor cells (PGCs). Furthermore, the differentiation towards the adipocyte lineage declines in cathepsin S 
knockout mice. In addition, data from our laboratory suggest that in these mice a mild, ongoing inflammation is 
present. In consequence, circulating blood monocytes are recruited to the site of issue and differentiate into 
inflammatory macrophages. Moreover, resident tissue macrophages may get activated to an immunological 
phenotype and therefore reduce their supportive role in bone formation. 
 
 
As cathepsin S favors the differentiation of MSCs towards adipocytes, it exhibits a 
profound pro-adipogenic effect. Moreover, it was proposed as a potent biomarker 
of adiposity [60]. Thus, cathepsin S seems to be critically involved in the 
development and pathogenesis of obesity. Therefore, the selective inhibition of 
cathepsin S may be a therapeutic possibility to treat adiposity, as proposed by 
Naour et al. [61].  Furthermore, cathepsin S inhibition in mouse models of several 
immune disorders such as multiple sclerosis, rheumatoid arthritis and 
atherosclerosis [62, 63] showed beneficial effects. Given the possible clinical 
relevance of the application of cathepsin S inhibitors, it has to be evaluated, if this 
positive effect outweighs the negative influences of cathepsin S inhibition on bone.  
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HBSS Hank’s Balanced Salt Solution 
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Ma.V marrow volume 
M-CSF macrophage colony-stimulating factor 
MEM minimum essential medium 
MFI mean fluorescence intensity 
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PTHrP parathyroid hormone-related peptide 
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RT room temperature 
SSC sideward scatter 
T cell T lymphocyte  
Tb.N trabecular number 
Tb.Sp trabecular separation 
Tb.Th trabecular thickness 
TGF-β transforming growth factor-β 
TissBMD tissue bone mineral density 
TNF- α tumor necrosis factor-α  
TRAP tartrate-resistant acid phosphatase 
Tris tris(hydroxymethyl)aminomethane 
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